Montelukast Refill Online in California
Montelukast (brand name Singulair) is a once-daily leukotriene receptor antagonist used to control asthma and relieve allergic rhinitis symptoms. California residents who are already stable on montelukast can request a refill online through an asynchronous telehealth visit — no video call required. DrRefills.com connects you with a board-certified physician who reviews your case and, if appropriate, sends a prescription to your pharmacy within one hour for a flat $59 fee, only charged if approved.
Already Taking Montelukast? Refill It Today
Skip the waiting room. A board-certified California MD reviews your request and sends your prescription to your local pharmacy in under an hour. $59, only charged if approved.
Start my refill →What Is Montelukast and How Does It Work?
Montelukast belongs to a class of medications called leukotriene receptor antagonists (LTRAs). Leukotrienes are inflammatory chemicals your immune system releases in response to allergens, exercise, cold air, or other triggers. In people with asthma or allergies, this leukotriene response can be overactive — causing airway swelling, excess mucus production, nasal congestion, and bronchoconstriction.
Montelukast works by blocking the cysteinyl leukotriene CysLT1 receptor, interrupting this inflammatory cascade before it causes symptoms. Unlike inhaled corticosteroids, montelukast is taken as an oral tablet or chewable and works systemically. Unlike antihistamines, it specifically targets the leukotriene pathway rather than the histamine pathway — which is why some patients benefit from taking both.
The FDA first approved montelukast in 1998 under the brand name Singulair. Generic versions have been widely available since 2012, making it an affordable long-term option for millions of Americans. It is not a rescue medication — it does not provide immediate relief during an asthma attack or acute allergy flare. It is a daily controller medication meant to reduce the frequency and severity of symptoms over time.
What Conditions Is Montelukast FDA-Approved to Treat?
Montelukast has three FDA-approved indications:
- Asthma (ages 12 months and older): Used as a daily controller to reduce asthma attacks, nighttime awakenings, and the need for rescue inhalers. It is typically prescribed as an add-on therapy alongside an inhaled corticosteroid, though some patients with mild persistent asthma use it as monotherapy.
- Seasonal allergic rhinitis (ages 2 years and older): Helps reduce sneezing, nasal congestion, runny nose, and itchy eyes caused by seasonal allergens like pollen and grass.
- Perennial allergic rhinitis (ages 6 months and older): Treats year-round allergic rhinitis triggered by dust mites, pet dander, mold, and other persistent allergens.
Some physicians also use montelukast off-label for exercise-induced bronchoconstriction and chronic urticaria (hives), though these are not FDA-approved indications.
What Is the Standard Montelukast Dosing?
| Age Group | Indication | Dose | Formulation |
|---|---|---|---|
| Adults and adolescents ≥15 years | Asthma or allergic rhinitis | 10 mg once daily | Film-coated tablet |
| Children 6–14 years | Asthma or allergic rhinitis | 5 mg once daily | Chewable tablet |
| Children 2–5 years | Asthma or allergic rhinitis | 4 mg once daily | Chewable tablet or granules |
| Children 12–23 months | Asthma only | 4 mg once daily | Oral granules |
| Children 6–23 months | Perennial allergic rhinitis | 4 mg once daily | Oral granules |
For asthma, montelukast is typically taken in the evening. For allergic rhinitis alone, it can be taken at any time of day. No dose adjustment is required for patients with mild to moderate hepatic impairment, though patients with severe liver disease should discuss dosing carefully with their physician. No renal dose adjustment is needed.
Montelukast is not a fast-acting rescue medication. It must be taken every day for consistent symptom control, even on days when you feel well. Stopping it abruptly may cause a return of symptoms within days.
What Is the FDA Boxed Warning for Montelukast?
In March 2020, the FDA added its most serious type of warning — a boxed warning — to montelukast's prescribing information. This was based on reports of serious neuropsychiatric events in patients taking the drug. This is one of the most important things to understand about montelukast before starting or continuing it.
What Neuropsychiatric Side Effects Have Been Reported?
The boxed warning covers a range of mental health and behavioral changes that have been reported in both children and adults taking montelukast. These include:
- Agitation and aggressive behavior or hostility
- Anxiousness and irritability
- Attention problems and hyperactivity
- Depression
- Disorientation or confusion
- Dreaming abnormalities, including vivid or disturbing dreams and nightmares
- Hallucinations
- Insomnia and sleep disturbances
- Memory impairment
- Obsessive-compulsive symptoms
- Restlessness and tremor
- Suicidal thinking and behavior (including completed suicide)
These events have been reported during treatment and after discontinuation of the drug. They can occur at any age, in patients with or without a prior history of psychiatric illness. The onset may be abrupt or gradual, and symptoms may not be immediately recognized as medication-related.
What Does the FDA Recommend Because of This Warning?
The FDA now recommends that montelukast generally be reserved for patients with allergic rhinitis who do not respond adequately to or cannot tolerate other allergy treatments (such as antihistamines or intranasal corticosteroids). For asthma, it remains an appropriate controller option, but prescribers are advised to weigh the risks and benefits for each individual patient.
Patients and caregivers should be counseled to watch for behavioral and mood changes and to contact their physician immediately if such changes occur. The medication should be discontinued if neuropsychiatric symptoms develop.
This warning does not mean montelukast is unsafe for everyone. Millions of patients take it without experiencing any psychiatric side effects. It does mean that patients and physicians need to have an informed conversation about risks before starting or continuing the medication — particularly for patients who already have anxiety, depression, or other psychiatric conditions.
Who Is a Good Candidate for an Async Montelukast Refill?
An asynchronous telehealth refill is appropriate when you are already stable on montelukast and simply need a continuation of a prescription that has been working for you. The right candidate for this service generally looks like this:
- You are an adult (18 years or older) living in California
- You have been prescribed montelukast before by a licensed physician
- Your asthma or allergic rhinitis symptoms are well-controlled on your current dose
- You have not experienced any new mood changes, sleep disturbances, or behavioral changes you suspect may be related to montelukast
- You do not have new or worsening asthma symptoms that suggest your condition has changed
- You are not experiencing a respiratory emergency
When Should You See Your Doctor In Person Instead?
A telehealth refill is not a substitute for a comprehensive asthma or allergy evaluation. You should see your physician in person if:
- Your asthma is not well-controlled despite taking montelukast and other medications
- You have needed your rescue inhaler more than twice a week
- You have had an emergency room visit or hospitalization for asthma
- You are experiencing new anxiety, depression, unusual dreams, or behavioral changes
- You have never been formally evaluated for asthma or allergic rhinitis
- You are pregnant or trying to become pregnant (discuss risk-benefit carefully with your OB or internist)
- Your symptoms suggest a new or different diagnosis
Stable on Montelukast? Let Us Handle the Refill
DrRefills.com is California's async telehealth service for chronic medication refills. A board-certified MD reviews your case — no video call, no waiting room. $59 flat fee, only charged if your refill is approved. Prescription sent to your pharmacy in under one hour.
Start my refill →How Does Montelukast Compare to Other Allergy and Asthma Controllers?
| Medication | Type | Best For | Key Consideration |
|---|---|---|---|
| Montelukast (Singulair) | Leukotriene receptor antagonist (oral) | Asthma + allergic rhinitis together; exercise-triggered symptoms | FDA boxed warning for neuropsychiatric events |
| Fluticasone nasal spray (Flonase) | Intranasal corticosteroid | Allergic rhinitis (first-line) | OTC available; preferred first-line for rhinitis |
| Cetirizine / Loratadine | Second-generation antihistamine (oral) | Mild to moderate allergic rhinitis | OTC available; works faster than montelukast |
| Inhaled corticosteroids (ICS) | Anti-inflammatory (inhaled) | Persistent asthma (first-line controller) | Preferred controller for most asthma patients |
| Long-acting beta-agonists (LABA) | Bronchodilator (inhaled) | Moderate-severe asthma as add-on to ICS | Never used alone without ICS |
For allergic rhinitis, current guidelines from the American Academy of Allergy, Asthma & Immunology (AAAAI) recommend intranasal corticosteroids as first-line treatment, with antihistamines as a reasonable second option. Montelukast is considered a third-line option for rhinitis specifically because of the 2020 boxed warning — though it remains a reasonable choice when other treatments are inadequate or not tolerated.
For asthma, montelukast occupies a legitimate place in the step-care approach as an alternative or add-on controller, particularly for patients who have difficulty with inhaler technique, concurrent allergic rhinitis, or aspirin-exacerbated respiratory disease.
How to Get a Montelukast Refill Online in California
- Visit DrRefills.com and select montelukast (or Singulair) as your medication.
- Answer a brief health questionnaire about your diagnosis, current dose, symptom control, and any side effects you have noticed — especially mood or behavioral changes.
- A board-certified California physician reviews your information asynchronously — no video call required.
- If appropriate, your prescription is approved and sent electronically to your chosen California pharmacy within one hour.
- The $59 fee is only charged if your refill is approved. If the physician determines an in-person visit is needed instead, you are not charged.
This process is fully HIPAA-compliant and uses a secure platform. It is designed for established patients who are stable on their current regimen — not for initiating new medications or evaluating new or changing symptoms.
Ready to Refill Your Montelukast?
Don't let your prescription lapse. Get a same-day refill from a board-certified California MD — async, convenient, and only $59 if approved. Most prescriptions sent to your pharmacy in under one hour.
Start my refill →Frequently Asked Questions About Montelukast Refills Online
Yes. DrRefills.com uses asynchronous telehealth, which means you submit your health information through a secure questionnaire and a board-certified California MD reviews it on their end — no video appointment necessary. If approved, your prescription is sent to your pharmacy within one hour. This model is fully legal under California telehealth law for appropriate refill requests.
Many patients take montelukast safely for years. The FDA boxed warning means you and your physician need to be aware of the potential for neuropsychiatric side effects — not that the drug must be stopped in all cases. If you have not experienced any mood changes, sleep disturbances, depression, or behavioral changes on montelukast, continuing it under physician supervision is generally considered appropriate. Always discuss your individual risk profile with your doctor.
For asthma, montelukast is recommended in the evening, since many asthma symptoms worsen overnight. For allergic rhinitis alone, it can be taken at any consistent time each day. The most important